Danaher

Yahoo Finance • 5 days ago

Wix downgraded, TripAdvisor upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Bilibili (BILI) to Buy f... Full story

Yahoo Finance • 6 days ago

Danaher Achieves #26 Analyst Rank, Surpassing Insulet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Danaher Corp (Symbol: DHR) has taken over the #26 spot from Insulet Corp (Symbol: PODD), according to ETF Channel. Below is a cha... Full story

Yahoo Finance • 6 days ago

S&P 500 Analyst Moves: DHR

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Danaher is now the #71 analyst pick, moving up by 22 spots. This rank is formed by averaging the analyst opinions f... Full story

Yahoo Finance • 12 days ago

U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 Million - Analysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More

Company Logo U.S. Exosomes MarketU.S. Exosomes Market·GlobeNewswire Inc. Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "U.S. Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Application, Workflow, End Use, and... Full story

Yahoo Finance • 19 days ago

1 S&P 500 Stock Worth Your Attention and 2 Facing Headwinds

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, decl... Full story

Yahoo Finance • 21 days ago

Jim Cramer on Agilent Technologies: “I Don’t Think You Need It”

Agilent Technologies, Inc. (NYSE:A) is one of the stocks on which Jim Cramer expressed his thoughts. A caller asked if the stock will ever come back, and here’s what Cramer had to say in response: You know, they do so much test and measur... Full story

Yahoo Finance • 22 days ago

Assessing Danaher (DHR) Valuation After New AI Partnership In Clinical Diagnostics

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Danaher (DHR) is back in focus after Beckman Coulter Diagnostics,... Full story

Yahoo Finance • 28 days ago

Notable ETF Outflow Detected - IWV, PM, COP, DHR

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 3000 ETF (Symbol: IWV) where we have detected an approximate $600.4 million dollar outflow --... Full story

Yahoo Finance • 28 days ago

Maintenance Repair Operations for Automation Solutions Business Report 2026: Market to Surpass $150 Billion by 2030 as Growth in High-Speed, Multi-Axis Manufacturing Lines Propels Demand

Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "Maintenance Repair Operations for Automation Solutions Market - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Maint... Full story

Yahoo Finance • 29 days ago

Oversold Conditions For Danaher (DHR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 29 days ago

Pall Corporation Appoints Dr. Roland Folz as President

PORT WASHINGTON, N.Y., March 3, 2026 /PRNewswire/ -- Pall Corporation, a Danaher company and a global leader in filtration, separation and purification, announced the appointment of Dr. Roland Folz as President, Pall Corporation, effective... Full story

Yahoo Finance • last month

Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer

Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services,... Full story

Yahoo Finance • last month

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • last month

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts" report has been added to Rese... Full story

Yahoo Finance • last month

Masimo Buyout By Danaher Spurs Revaluation And Volatility Questions

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Danaher Corporation has agreed to acquire Masimo Corporation, posi... Full story

Yahoo Finance • last month

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

We came across a bullish thesis on Viking Therapeutics, Inc. on HalfBakedInnovations’s Substack by Biotech Distilled. In this article, we will summarize the bulls’ thesis on VKTX. Viking Therapeutics, Inc.'s share was trading at $29.30 as... Full story

Yahoo Finance • last month

Danaher (DHR) is Gaining from Improvement in Its Bioprocessing Business

Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for the “Madison Large Cap Fund”. A copy of the letter can be downloaded here. In the fourth quarter, the S&P 500 returned 2.65%, resulting in a f... Full story

Yahoo Finance • last month

Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics

Company Logo By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled by high demand for rapid and accessibl... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

Wall Street’s major market averages concluded higher on Friday as investors reacted to the latest PCE inflation report, which came in hotter than expected. The tech-focused Nasdaq Composite ended +0.9%. At the same time, the benchmark S&P... Full story

Yahoo Finance • last month

Here are 3 forces that drove the stock market during Wall Street’s comeback week

The stock market staged a comeback last week, even as Wall Street waded through a flurry of both upbeat and unsettling headlines. The Nasdaq broke its five-week losing streak on Friday, buoyed by strong advances from our big tech names lik... Full story